Advances in Rheumatology

Papers
(The H4-Index of Advances in Rheumatology is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
COVID-19 on patients with immune-mediated rheumatic disease: a comparative study of disease activity, fatigue, and psychological distress over six months28
Efficacy of two doses of intra-articular ozone therapy for pain and functional mobility in knee osteoarthritis: a double-blind randomized trial27
Evaluation of core decompression outcome in systemic lupus erythematosus with hip osteonecrosis: a retrospective cohort study26
Effect of multidimensional physiotherapy on non-specific chronic low back pain: a randomized controlled trial25
The use of high-sensitivity cardiac troponin I in assessing cardiac involvement and Disease prognosis in idiopathic inflammatory myopathy22
Dual seropositive nonerosive lupus arthritis: rhupus or not?18
Clinical and laboratory evaluation of sicca complaints: distinctive aspects of primary, secondary and non-Sjogren syndrome17
Translation, cultural adaptation and reproducibility of a Portuguese version of the Functional Index for Hand OsteoArthritis (FIHOA)17
Effect of curcumin on the expression of NOD2 receptor and pro-inflammatory cytokines in fibroblast-like synoviocytes (FLSs) of rheumatoid arthritis (RA) patients15
Assessment of gait in patients with fibromyalgia during motor and cognitive dual task walking: a cross-sectional study15
Four-years retention rate of golimumab administered after discontinuation of non-TNF inhibitors in patients with inflammatory rheumatic diseases14
The impact of hospitalization on mortality in patients with connective tissue disease-associated interstitial lung disease: a medical records review study14
Unraveling the genetic collagen connection: clinical and therapeutic insights on genetic connective tissue disorders13
Referrals for rheumatologic evaluation following a positive antinuclear antibody test result. A cross-sectional single center Brazilian study13
0.079080104827881